Mckesson

MCK on NYSE. McKesson sells medicines, medical supplies, and services to pharmacies, hospitals, and doctors. Market value $106.7bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to March 2026.

Should I look at this?

Not a fit for our list right now

See Health care stocks that passed both tests

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to June 2026
6.0%high

For every $100 of what the whole company costs, it produced $6.01 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to June 2026
17.1×full

You pay 17.1 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to March 2026
n/a

The filings do not give us enough to work this out.

Quality score: 51 of 100. Price score: 81 of 100. Our list needs 70 on quality and 60 on price.

$915.45 a share, 26% above its 1-year low

Over the past year the price has ranged from $723.68 to $999.00.

Dividend: 0.4% a year

Paid every year for at least 5 years

Prices from Monday’s close (5 October).

Five years of cash, in billions

4.0
4.8
3.9
5.5
5.7
6.4
2022202320242025202612 monthsto Jun '26
Revenue
$264.0bn$276.7bn$309.0bn$359.1bn$403.4bn
Operating margin
0.8%1.6%1.3%1.2%1.5%
Debt to equity
n/an/an/an/an/a
Shares outstanding
0.14bn0.13bn0.13bn0.12bn0.12bn

Health checks

  • Free cash flow positive5 of 5 years
  • Accounting looks honest (Beneish)Nothing unusual
  • Financial strength (Piotroski)5 of 8 checks we could run
  • Profit backed by cash (accruals)Yes
  • DebtUnknown
  • Revenue growth, five yearsStrong, 11.1% a year
  • Buying back its own sharesYes, 15% fewer since 2022

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $105.4 billion last quarter, up 8% on a year ago.
  • Profit: $614 million, down 22% on a year ago.
  • It keeps 2 cents of each $1 of sales as operating profit, up from 1 cents a year earlier.
  • Spare cash over the past 12 months: $6.4 billion, up from $6 billion.
  • 5% fewer shares than a year ago. Each share owns a bit more of the company.
  • Debt is $4.5 billion more than cash, down from $5.4 billion a year ago.
  • Sales grew on a year ago in each of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$93.7bn
December 2024$95.3bn
March 2025$90.8bn
June 2025$97.8bn
September 2025$103.2bn
December 2025$106.2bn
March 2026$96.3bn
June 2026$105.4bn
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024$241m
December 2024$879m
March 2025$1.3bn
June 2025$784m
September 2025$1.1bn
December 2025$1.2bn
March 2026$1.7bn
June 2026$614m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
4 November 2026
Last annual report (10-K)
8 May 2026
Next quarterly (estimated, 10-Q)
4 November 2026

Who owns it

8 long-term investors we follow own it, up from 7 last quarter. 2,011 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

2 investors own more than 5%.

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought shares on the open market in the last 12 months. 7 sold $28m, $28m of it under preset trading plans.

  • Rutledge Napoleon B JR
    SVP, Controller & CAO
    Sold
    under a preset trading plan
    Date
    8 September 2026
    Shares
    111
    Price
    $891.45
    Value
    $98,951
  • Lerman Bradley E
    Director
    Sold
    Date
    10 August 2026
    Shares
    301
    Price
    $892.33
    Value
    $268,590
  • TYLER BRIAN S.
    Chief Executive Officer, Director
    Sold
    under a preset trading plan
    Date
    7 July 2026
    Shares
    8,463
    Price
    $793.56
    Value
    $7m
  • TYLER BRIAN S.
    Chief Executive Officer, Director
    Sold
    under a preset trading plan
    Date
    17 June 2026
    Shares
    8,463
    Price
    $775.13
    Value
    $7m
  • TYLER BRIAN S.
    Chief Executive Officer, Director
    Sold
    under a preset trading plan
    Date
    9 June 2026
    Shares
    4,929
    Price
    $763.00
    Value
    $4m
  • Rutledge Napoleon B JR
    SVP, Controller & CAO
    Sold
    under a preset trading plan
    Date
    5 June 2026
    Shares
    133
    Price
    $764.00
    Value
    $101,612
  • Rodgers Thomas L
    EVP, Chief Strategy & BDO
    Sold
    under a preset trading plan
    Date
    2 June 2026
    Shares
    699
    Price
    $735.27
    Value
    $513,954
  • Rodgers Thomas L
    EVP, Chief Strategy & BDO
    Sold
    under a preset trading plan
    Date
    1 June 2026
    Shares
    123
    Price
    $735.50
    Value
    $90,467
  • Smith LeAnn B
    EVP & Chief HR Officer
    Sold
    under a preset trading plan
    Date
    1 June 2026
    Shares
    1,810
    Price
    $735.50
    Value
    $1m
  • Lau Michele
    EVP and Chief Legal Officer
    Sold
    under a preset trading plan
    Date
    26 May 2026
    Shares
    3,550
    Price
    $761.09
    Value
    $3m

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 8 May 2026, plus the 10-Q filed 5 Aug 2026 and 5 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

  • It owes more than it owns on paper (negative equity). Often that's from borrowing to buy back shares.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.